David Musket Insider Profile

David Musket, Director at Capricor Therapeutics, holds 30.64K shares in Capricor Therapeutics (Ticker: CAPR). Most recently, David Musket Sold $28,215 shares of Capricor Therapeutics on Jul 01, 2022 for an estimated value of 106.37K.
David Musket

David Musket
Capricor Therapeutics (CAPR)

Ranked #85,331 out of 102,868 Corporate Insiders

Profitable Transactions

1 out of 5 Profitable Transactions

Average Return

Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

A breakdown of David Musket's holdings

Insider Roles

Capricor Therapeutics
Roles that David Musket holds in companies

Most Profitable Insider Trade

Capricor Therapeutics
Rating:Informative Buy
Date:Dec 29, 2021 - Dec 29, 2022
The most profitable trade made by David Musket

David Musket's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Capricor Therapeutics
Jul 01, 2022
Informative Sell
Success Rate for CAPR
1 out of 5 profitable transactions on CAPR
Average Return for CAPR
Average return per transaction on CAPR
No. of Shares
Price per Share
Link to Report
Jan 22, 2015
Informative Buy
May 11, 2017
Informative Buy
Dec 19, 2019
Uninformative Buy
Jun 29, 2022
Informative Sell
Jul 01, 2022
Informative Sell
List of latest transactions for each holding click on a transaction to see David Musket's performance on stock

David Musket insider profile FAQ

What is the percentage of profitable transactions made by David Musket?
The percentage of profitable transactions made by David Musket is 20%.
    What is the average return per transaction made by David Musket?
    The average return per transaction made by David Musket is -24.10%.
      What stocks does David Musket hold?
      David Musket holds: CAPR stocks.
        What was David Musket’s latest transaction?
        David Musket latest transaction was an Informative Sell of $106.37K.
          What was David Musket's most profitable transaction?
          David Musket’s most profitable transaction was an Informative Buy of CAPR stock on December 29, 2021. The return on the trade was 27.80%.
            What is David Musket's role in Capricor Therapeutics?
            David Musket's role in Capricor Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.